Study protocol for a double blind, randomised, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy: SUB-pectoral Local anaesthetic Infusion following MastEctomy (SUBLIME) study

BMJ Open. 2014 Sep 30;4(9):e006318. doi: 10.1136/bmjopen-2014-006318.

Abstract

Introduction: Over 16 000 mastectomies are performed in England and Wales annually. Acute postoperative pain and nausea are common. The most frequently occurring long-term complications are chronic pain (up to 50%) and reduced shoulder function (reported at 35%). Regional techniques that improve acute postoperative pain relief may reduce the incidence of these complications. This study assesses the effectiveness of a 24-hour continuous local anaesthetic in the subpectoral plane in improving postoperative pain and quality of life in patients undergoing mastectomy.

Methods and analysis: This is a randomised, double blind, placebo-controlled, two-centre, parallel group trial in women undergoing mastectomy with or without axillary involvement. One hundred and sixty participants will be randomised in a 1:1 ratio to receive either 0.25% levobupivacaine or 0.9% saline by subpectoral infusion postoperatively for 24 h. All participants will be provided with an intravenous morphine patient-controlled analgesia (PCA) system. Participants will be followed-up for 24 h in hospital and at approximately 14 days and 6 months postoperatively. Joint primary outcome measures are total morphine consumption and total pain score (captured via patient-recorded visual analogue scale (VAS) 4 hourly) during the first 24 h postoperatively. Primary statistical analysis of total pain is based on the area under the curve of pain versus time graph. Secondary outcomes include PCA attempts in first 24 h; VAS pain scores and shoulder function by goniometry at 24 h, 14 days (approximately) and 6 months; Verbal Rating Scale pain scores in first 24 h; Brief Pain Inventory and Oxford Shoulder Score at 6 months; duration of hospital stay; incidence of postoperative nausea and vomiting; cost-effectiveness.

Ethics and dissemination: The study is approved by the South West England Research Ethics Committee (12/SW/0149).

Results: will be published in a peer-reviewed journal and presented at local, national and international scientific meetings.

Trial registration: ISRCTN46621916. EudraCT 2011-005775-16.

Keywords: Anaesthetic infusion; Local Anaesthetic; Mastectomy; Pain; Shoulder function.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesia, Patient-Controlled / methods*
  • Anesthetics, Local / administration & dosage*
  • Anesthetics, Local / therapeutic use
  • Bupivacaine / administration & dosage
  • Bupivacaine / analogs & derivatives
  • Bupivacaine / therapeutic use
  • Clinical Protocols
  • Double-Blind Method
  • Female
  • Humans
  • Infusions, Intravenous / methods
  • Levobupivacaine
  • Mastectomy / adverse effects*
  • Pain Measurement
  • Pain, Postoperative / drug therapy*
  • Quality of Life
  • Shoulder / physiology*

Substances

  • Anesthetics, Local
  • Levobupivacaine
  • Bupivacaine

Associated data

  • EudraCT/2011-005775-16
  • ISRCTN/ISRCTN46621916